Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
16:30
THAE0301
Estimating country cost implications associated with new WHO HIV treatment guideline revisions: forecasting Cambodia's 5-year programme costs for adults
Jennifer Campbell, Clinton Health Access Initiative, United States
Abstract

16:45
THAE0302
Anticipated reductions in long-term tuberculosis incidence and associated cost savings with adoption of the Treat All People Living with HIV policy in Botswana, 2016-2035
Botshelo Kgwaadira, Ministry of Health, Botswana
Abstract
Slides

17:00
THAE0303
Assessing progress, impact, and next steps in rolling out voluntary medical male circumcision for HIV prevention in fourteen priority countries in eastern and southern Africa as of 2015
Emmanuel Njeuhmeli, United States Agency for International Development (USAID), United States
Abstract
Slides

17:15
THAE0304
Cost effectiveness of on demand PrEP in men who have sex with men (MSM) in the ANRS IPERGAY study
Isabelle Durand-Zaleski, Assistance Publique Hopitaux de Paris, France
Abstract
Slides

17:30
THAE0305
The cost-effectiveness of HIV pre-exposure prophylaxis (PrEP) in high-risk men who have sex with men (MSM) and transgendered women (TGW) in Brazil
Fabio Mesquita, Visiting Investigator from the School of Medicine of the University of São Paulo, Brazil
Abstract
Slides

17:45
THAE0306
Moderated discussion